CoChat

A phase 2 randomized, controlled trial of the α7 agonist ABT‐126 in mild‐to‐moderate Alzheimer's dementia

Open access
Gault, Laura M., Ritchie, Craig W., Robieson, Weining Z., Pritchett, Yili, Othman, Ahmed A., Lenz, Robert A. · 2015 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Cited by 41

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Introduction: The safety and efficacy of the novel α7 nicotinic acetylcholine receptor agonist ABT‐126 were investigated in subjects with mild‐to‐moderate Alzheimer's dementia (AD). Methods: Subjects not currently receiving acetylcholinesterase inhibitors were randomized to ABT‐126 (5 or 25 mg once daily), donepezil 10 mg once daily, or placebo for 12 weeks. The primary efficacy end point was the change from baseline to final evaluation in the 11‐item Alzheimer's Disease Assessment Scale‐cognitive subscale (ADAS‐Cog) total score. Results: A total of 274 subjects were randomized. Although the study did not meet its primary end point, trends toward improvement were seen with ABT‐126 25 mg (least squares mean [standard error] difference from placebo −1.19 [0.90]; one‐sided P = .095) and donepezil (−1.43 [0.90]; one‐sided P = .057) on the 11‐item ADAS‐Cog total score change from baseline to the final evaluation. ABT‐126 5 mg was numerically similar to placebo. An exposure‐response analysis indicated a statistically significant relationship between ABT‐126 exposure and the change from baseline in ADAS‐Cog, with no evidence of a plateau. No clinically meaningful differences in safety were observed among treatment groups. Discussion: Although the ABT‐126 25 mg dose did not demonstrate statistically significant improvement, results of the exposure‐response analysis suggest that higher doses may produce better efficacy, and the safety profile of ABT‐126 in this study supports additional studies with higher doses in subjects with mild‐to‐moderate AD. Clinical trial register number: NCT00948909 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trci.2015.06.001

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Gault, L. M., Ritchie, C. W., Robieson, W. Z., Pritchett, Y., Othman, A. A., & Lenz, R. A.
Venue
Alzheimer's & Dementia: Translational Research & Clinical Interventions
Publisher
Wiley
Published
2015-06
Volume
1
Issue
1
Pages
81-90
ISSN
2352-8737 (ISSN-L)
OpenAlex
W2138338009
Cited by
41
References
5
FWCI
3.23
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.